Trevi Therapeutics Inc —— 财务报表 (NASDAQ:TRVI) | MetaTrader

展开完整图表

新闻

Trevi Therapeutics, Inc. (TRVI) Q4 2025 Earnings Call Transcript

Zacks.com featured highlights include Trevi, Metalla Royalty & Streaming and Vermilion

Trevi Therapeutics股票因第三阶段试验计划获Oppenheimer看好

Trevi Therapeutics stock gets Oppenheimer nod on Phase 3 plans

Up Over 50%: 3 Stocks on the Verge of a Massive Breakout in March

Trevi计划开展两项针对特发性肺纤维化慢性咳嗽治疗的三期临床试验

Trevi plans two phase 3 trials for chronic cough treatment in IPF

Does Trevi Therapeutics (TRVI) Have the Potential to Rally 102.07% as Wall Street Analysts Expect?

Trevi的纳布芬缓释片显示显著减少IPF咳嗽

Trevi’s nalbuphine ER shows significant reduction in IPF cough

Trevi Therapeutics计划与FDA会面讨论慢性咳嗽项目

Trevi Therapeutics schedules FDA meeting for chronic cough program